Related Experiment Videos
Can albuterol help resistance exercise attenuate unloading-induced bone loss?
John F Caruso1, John L Hamill, Miki Yamauchi
1Exercise Physiology Laboratory, University of Nevada, Reno, NV 89557, USA. john_caruso@utulsa.edu
Journal of Strength and Conditioning Research
|December 3, 2004
Summary
Beta-agonist albuterol combined with resistance exercise significantly increased bone mineral content in unloaded limbs. This combination may help maintain mechanical loading to prevent bone loss during inactivity.
Area of Science:
- Exercise Physiology
- Bone Metabolism
- Pharmacology
Background:
- Unloading-induced bone loss is a significant concern in various physiological and clinical conditions.
- Beta(2)-agonists have shown potential in attenuating bone loss in animal models.
- Resistance exercise is known to stimulate bone formation in humans.
Purpose of the Study:
- To investigate the efficacy of the beta(2)-agonist albuterol in conjunction with resistance exercise for mitigating unloading-induced bone loss.
- To determine if albuterol enhances the bone-protective effects of resistance training during limb suspension.
Main Methods:
- Human subjects underwent 40 days of unilateral lower limb suspension.
- Subjects performed left leg resistance training three times per week.
- Concurrent treatment with either placebo or albuterol (16 mg/day) was administered.
- Bone mineral content and mechanical loading were analyzed using ANCOVA and ANOVA.
Main Results:
- The resistance exercise-albuterol group demonstrated significant bone mineral content gains (+2.24%) in the unloaded limb.
- The resistance exercise-placebo group experienced a significant decline (-13.91%) in mechanical loading.
- Albuterol appeared to preserve the mechanical loading stimulus provided by resistance exercise.
Conclusions:
- Combined albuterol and resistance exercise can lead to bone mineral content gains during unloading.
- Albuterol may enhance bone adaptation to resistance exercise by maintaining mechanical loading.
- This therapeutic strategy holds promise for preventing bone loss in disuse conditions.